Cargando…

Circulating lipid profiles are associated with cross-sectional and longitudinal changes of central biomarkers for Alzheimer’s disease

Investigating the association of lipidome profiles with central Alzheimer’s disease (AD) biomarkers, including amyloid/tau/neurodegeneration (A/T/N), can provide a holistic view between the lipidome and AD. We performed cross-sectional and longitudinal association analysis of serum lipidome profiles...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jun Pyo, Nho, Kwangsik, Wang, Tingting, Huynh, Kevin, Arnold, Matthias, Risacher, Shannon L., Bice, Paula J., Han, Xianlin, Kristal, Bruce S., Blach, Colette, Baillie, Rebecca, Kastenmüller, Gabi, Meikle, Peter J., Saykin, Andrew J., Kaddurah-Daouk, Rima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312871/ https://www.ncbi.nlm.nih.gov/pubmed/37398438 http://dx.doi.org/10.1101/2023.06.12.23291054

Ejemplares similares

Serum metabolites associated with brain amyloid beta deposition, cognition and dementia progression
por: Nho, Kwangsik, et al.
Publicado: (2021)

Circular-SWAT for deep learning based diagnostic classification of Alzheimer's disease: application to metabolome data
por: Jo, Taeho, et al.
Publicado: (2023)

Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers
por: Nho, Kwangsik, et al.
Publicado: (2019)

Bile acids targeted metabolomics and medication classification data in the ADNI1 and ADNIGO/2 cohorts
por: St. John-Williams, Lisa, et al.
Publicado: (2019)

Sets of coregulated serum lipids are associated with Alzheimer's disease pathophysiology
por: Barupal, Dinesh Kumar, et al.
Publicado: (2019)

Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer’s disease and progressive supranuclear palsy
por: Batra, Richa, et al.
Publicado: (2023)

Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer’s disease
por: Baloni, Priyanka, et al.
Publicado: (2022)

Integrative metabolomics‐genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease
por: Horgusluoglu, Emrin, et al.
Publicado: (2021)

Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome
por: Arnold, Matthias, et al.
Publicado: (2020)

Deep learning detection of informative features in tau PET for Alzheimer’s disease classification
por: Jo, Taeho, et al.
Publicado: (2020)

Targeted metabolomics and medication classification data from participants in the ADNI1 cohort
por: St John-Williams, Lisa, et al.
Publicado: (2017)

Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics
por: Hirschfeld, Lauren Rose, et al.
Publicado: (2022)

Metabolic Network Analysis Reveals Altered Bile Acid Synthesis and Metabolism in Alzheimer’s Disease
por: Baloni, Priyanka, et al.
Publicado: (2020)

The Metabolome-Wide Signature of Major Depressive Disorder
por: Jansen, Rick, et al.
Publicado: (2023)

Fused multi-modal similarity network as prior in guiding brain imaging genetic association
por: He, Bing, et al.
Publicado: (2023)

Peripheral serum metabolomic profiles inform central cognitive impairment
por: Wang, Jingye, et al.
Publicado: (2020)

Genome-Wide Association Analysis across Endophenotypes in Alzheimer’s Disease: Main Effects and Disease Stage-Specific Interactions
por: Rosewood, Thea J., et al.
Publicado: (2023)

Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study
por: Varma, Vijay R., et al.
Publicado: (2018)

APOE ε2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studies
por: Wang, Tingting, et al.
Publicado: (2022)

Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer’s disease
por: Huynh, Kevin, et al.
Publicado: (2020)

Genetic variation affecting exon skipping contributes to brain structural atrophy in Alzheimer’s disease
por: Lee, Younghee, et al.
Publicado: (2018)

Integrative analysis of eQTL and GWAS summary statistics reveals transcriptomic alteration in Alzheimer brains
por: Varathan, Pradeep, et al.
Publicado: (2022)

Association of the top 20 Alzheimer's disease risk genes with [(18)F]flortaucipir PET
por: Stage, Eddie, et al.
Publicado: (2022)

BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s disease
por: Kim, Jun Pyo, et al.
Publicado: (2021)

Correction to: BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s disease
por: Kim, Jun Pyo, et al.
Publicado: (2022)

Hippocampal transcriptome-guided genetic analysis of correlated episodic memory phenotypes in Alzheimer's disease
por: Yan, Jingwen, et al.
Publicado: (2015)

Identification of exon skipping events associated with Alzheimer’s disease in the human hippocampus
por: Han, Seonggyun, et al.
Publicado: (2019)

Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways
por: Horgusluoglu-Moloch, Emrin, et al.
Publicado: (2019)

From phenotype to genotype: an association study of longitudinal phenotypic markers to Alzheimer's disease relevant SNPs
por: Wang, Hua, et al.
Publicado: (2012)

Metabolic Profiling of Patients with Schizophrenia
por: Kaddurah-Daouk, Rima
Publicado: (2006)

Two-dimensional enrichment analysis for mining high-level imaging genetic associations
por: Yao, Xiaohui, et al.
Publicado: (2016)

Rare variants in the splicing regulatory elements of EXOC3L4 are associated with brain glucose metabolism in Alzheimer’s disease
por: Miller, Jason E., et al.
Publicado: (2018)

Integration of plasma and CSF metabolomics with CSF proteomic reveals novel associations between lipid mediators and central nervous system vascular and energy metabolism
por: Borkowski, Kamil, et al.
Publicado: (2023)

Deep Learning in Alzheimer's Disease: Diagnostic Classification and Prognostic Prediction Using Neuroimaging Data
por: Jo, Taeho, et al.
Publicado: (2019)

Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer’s disease
por: Borkowski, Kamil, et al.
Publicado: (2021)

Dysregulated expression levels of APH1B in peripheral blood are associated with brain atrophy and amyloid-β deposition in Alzheimer’s disease
por: Park, Young Ho, et al.
Publicado: (2021)

Immunity gene IFITM3 variant: Relation to cognition and Alzheimer's disease pathology
por: Pyun, Jung‐Min, et al.
Publicado: (2022)

Comprehensive genetic analysis of the human lipidome identifies loci associated with lipid homeostasis with links to coronary artery disease
por: Cadby, Gemma, et al.
Publicado: (2022)

Neuropathological correlates and genetic architecture of microglial activation in elderly human brain
por: Felsky, Daniel, et al.
Publicado: (2019)

miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer’s disease
por: Han, Sang-Won, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_77icrsdefbm178aicpsdb9g15v